Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 218211
Company: GLAND

Products on ANDA 218211

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
EPHEDRINE SULFATE	EPHEDRINE SULFATE	50MG/10ML (5MG/ML)	SOLUTION;INTRAVENOUS	Prescription	AP1	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 218211

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/16/2025	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218211Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 218211

EPHEDRINE SULFATE

SOLUTION;INTRAVENOUS; 50MG/10ML (5MG/ML)
TE Code = AP1

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
EMERPHED	EPHEDRINE SULFATE	50MG/10ML (5MG/ML)	SOLUTION;INTRAVENOUS	Prescription	Yes	AP1	213407	NEXUS
EPHEDRINE SULFATE	EPHEDRINE SULFATE	50MG/10ML (5MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP1	218211	GLAND